drugset / Trial / NCT02458768

Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.

NCT02458768

Phase 4 Completed 112 enrolled LG Life Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study was to demonstrate the non-inferiority of IVFM HP Inj. by evaluating its efficacy versus Menopur® Inj. in infertility women undergoing the in vitro fertilization and embryo transfer (IVF-ET) among the assisted reproductive technologies.

Timeline

Start
2013-07
Primary completion
2014-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject IVF-M HP Unknown 225 iu Subcutaneous
Comparator Menopur Protein / enzyme biologic 225 iu Subcutaneous

Indications